MedTrace Logo

Simplification of Complex Insulin Regimens With Preserving Good Glycemic Control in Type 2 Diabetes

NCT04020445 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2023-02-13

No results posted yet for this study

Summary

This study examines prospectively the safety and efficacy of switching from multiple daily insulin injections (MDI) to once daily IDegLira (insulin degludec and liraglutide fix ratio combination), a fixed-ratio combination of insulin degludec and liraglutide, in relatively well controlled (HbA1c\<7.5%) subjects with type 2 diabetes using low total daily insulin dose (TDD).

Conditions

Interventions

OTHER

de-escalation of complex insulin regimens

complex insulin regimens are switched to fix ratio combinations consisting of of a basal insulin and a GLP-1 (glucagon-like peptide-1) receptor agonist

Sponsors & Collaborators

  • University of Debrecen

    collaborator OTHER

  • Szeged University

    collaborator OTHER

  • Bekes County Central Hospital

    lead OTHER

Principal Investigators

  • Zoltán J Taybani, MD · Bekes County Central Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2022-01-01
Completion
2022-01-01

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04020445 on ClinicalTrials.gov